Brief: Shanghai Junshi Biosciences Posts FY Loss Attributable Of RMB1,282 Mln
27/03/2025 15:50
March 27 (Reuters) - Shanghai Junshi Biosciences Co Ltd 688180.SS: LOSS ATTRIBUTABLE FOR YEAR RMB1,282 MILLION AS AT 31 DECEMBER 2024, TOTAL REVENUE RMB1,948 MILLION Further company coverage: 688180.SS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Junshi Biosciences
See all newsBrief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Receives Supplemental Drug Approval From NMPA
Brief: Shanghai Junshi Biosciences's Shareholder Plans To Cut Stake
Brief: Shanghai Junshi Biosciences Gets NMPA Acceptance Notice Of Supplemental Application For Toripalimab